Back
AbbVie 10K Form
Buy
60
ABBV
AbbVie
Last Price:
155.27
Seasonality Move:
5.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-04 | 10Q | ABBV/AbbVie Quarterly |
| 2020-05-08 | 10Q | ABBV/AbbVie Quarterly |
| 2020-02-21 | 10K | ABBV/AbbVie Annual |
| 2019-11-06 | 10Q | ABBV/AbbVie Quarterly |
| 2019-08-05 | 10Q | ABBV/AbbVie Quarterly |
| 2019-05-03 | 10Q | ABBV/AbbVie Quarterly |
Receive ABBV News And Ratings
See the #1 stock for the next 7 days that we like better than ABBV
ABBV Financial Statistics
Sales & Book Value
| Annual Sales: | $58.05B |
|---|---|
| Cash Flow: | $7.22B |
| Price / Cash Flow: | 11.27 |
| Annual Sales: | $9.75 |
| Price / Book: | 15.76 |
Profitability
| EPS (TTM): | 6.61000 |
|---|---|
| Net Income (TTM): | $11.84B |
| Gross Margin: | $40.64B |
| Return on Equity: | 74.35% |
| Return on Assets: | 8.3% |
AbbVie Earnings Forecast
Key AbbVie Financial Ratios
- The Gross Profit Margin over the past 14 years for ABBV is 70.00%.
- The Selling, General & Administrative Expenses for ABBV have been equal to 26.29% of Gross Profit Margin.
- The Research & Development expenses have been 11.21% of Revenue.
- The Interest Expense is 18.84% of Operating Income.
- The Net Earning history of ABBV is 20.39% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 7 years.
AbbVie Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | ABBV |
| CUSIP: | 00287Y |
| Website: | abbvieinvestor.com |
Debt
| Debt-to-Equity Ratio: | 3.67 |
|---|---|
| Current Ratio: | 0.96 |
| Quick Ratio: | 0.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.18 |
|---|---|
| Forward P/E Ratio: | 13.84 |